Dyakov I.N. - Publications list

Records list

Show:

PHARMACOECONOMIC EVALUATION OF FIRST-LINE COMBINATION THERAPY WITH IMMUNOTHERAPY DRUGS AND PLATINUM-CONTAINING CHEMOTHERAPY IN ADULT PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER

Article

Зырянов С.К., Дьяков И.Н.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 17. 2024. P.. 22-29

COST-EFFECTIVENESS ANALYSIS OF ACALABRUTINIB IN TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY FORM OF MANTLE CELL LYMPHOMA WHO PREVIOUSLY RECEIVED AT LEAST ONE LINE OF THERAPY

Article

Зырянов С.К., Дьяков И.Н.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 17. 2024. P.. 129-136

ECONOMIC EFFECTIVENESS OF FIXED-DOSE COMBINATION OF ALOGLIPTIN AND PIOGLITAZONE IN DIABETES MELLITUS TREATMENT

Article

Zyryanov S.К., Dyakov I.N.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 17. 2024. P.. 442-452

ФАРМАКОЭКОНОМИЧЕСКИЙ АНАЛИЗ ПРИМЕНЕНИЯ ПРЕПАРАТОВ УПАДАЦИТИНИБА, БАРИЦИТИНИБА И ДУПИЛУМАБА ДЛЯ СИСТЕМНОЙ ТЕРАПИИ ПАЦИЕНТОВ С АТОПИЧЕСКИМ ДЕРМАТИТОМ СРЕДНЕТЯЖЁЛОГО И ТЯЖЁЛОГО ТЕЧЕНИЯ

Article

Зырянов С.К., Дьяков И.Н., Ильина Н.И.

Качественная клиническая практика. 2023. P.. 70-84

UPDATED PHARMACOECONOMIC ANALYSIS OF ATESOLIZUMAB EFFICIENCY COMPARED WITH OTHER PD-1 INHIBITORS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AFTER CHEMOTHERAPY

Article

Зырянов С.К., Дьяков И.Н.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 16. 2023. P.. 422-430

PHARMACOECONOMIC ANALYSIS OF THE USE OF A FIXED COMBINATION OF TIOTROPIUM BROMIDE AND OLODATEROL AS MAINTENANCE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE RUSSIAN FEDERATION

Article

Зырянов С.К., Дьяков И.Н.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 15. 2022. P.. 188-198

PHARMACOECONOMICS ANALYSIS OF USING A FIXED COMBINATION OF BUDESONIDE/FORMOTEROL IN PATIENTS WITH ASTHMA IN THE HEALTH CARE SYSTEM OF THE RUSSIAN FEDERATION

Article

Зырянов С.К., Дьяков И.Н., Айсанов З.Р.

Terapevticheskii Arkhiv. Vol. 94. 2022. P.. 850-858

ФАРМАКОЭКОНОМИЧЕСКОЕ СРАВНЕНИЕ АНАЛОГОВ ИНСУЛИНА ВТОРОГО ПОКОЛЕНИЯ И ПРЕПАРАТОВ НА ИХ ОСНОВЕ

Article

Дьяков И.Н., Зырянов С.К.

Качественная клиническая практика. 2021. P.. 4-15

ФАРМАКОЭКОНОМИЧЕСКИЕ ХАРАКТЕРИСТИКИ АГОНИСТОВ РЕЦЕПТОРОВ ГЛЮКАГОНОПОДОБНОГО ПЕПТИДА-1 И ПРЕПАРАТОВ НА ИХ ОСНОВЕ

Article

Дьяков И.Н., Зырянов С.К.

Качественная клиническая практика. 2021. P.. 4-15

PHARMACOECONOMIC ASPECTS OF ORAL VINORELBINE APPLICATION: A BUDGET IMPACT ANALYSIS CONSIDERING THE NEW REGISTERED PRICE

Article

Иванов Д.А., Дьяков И.Н., Зырянов С.К.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Vol. 14. 2021. P.. 103-114

PHARMACOECONOMIC ANALYSIS OF TALIGLUCERASE ALFA USED IN THE RUSSIAN FEDERATION FOR GAUCHER’S DISEASE

Article

Дьяков И.Н., Зырянов С.К.

Medical Technologies. Assessment and Choice. 2021. P.. 54-62

ЭКОНОМИЧЕСКАЯ СТОРОНА ИНТЕНСИФИКАЦИИ ПЕРОРАЛЬНОЙ САХАРОСНИЖАЮЩЕЙ ТЕРАПИИ АГОНИСТАМИ РЕЦЕПТОРОВ ГЛЮКАГОНОПОДОБНОГО ПЕПТИДА-1

Article

Зырянов С.К., Дьяков И.Н.

Качественная клиническая практика. 2021. P.. 4-15

FN3 PROTEIN FRAGMENT CONTAINING TWO TYPE III FIBRONECTIN DOMAINS FROM B. LONGUM GT15 BINDS TO HUMAN TUMOR NECROSIS FACTOR ALPHA IN VITRO

Article

Dyakov I.N., Mavletova D.A., Chernyshova I.N., Snegireva N.A., Gavrilova M.V., Bushkova K.K., Dyachkova M.S., Alekseeva M.G., Danilenko V.N.

Anaerobe. Vol. 65. 2020.

THE PHARMACOECONOMIC EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

Article

Зырянов С.К., Дьяков И.Н., Жуперин А.А., Егорова Д.А., Мосолова Е.С.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Vol. 120. 2020. P.. 82-91

COST ANALYSIS OF DUAL ANTIPLATELET THERAPY WITH PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION

Article

Дьяков И.Н., Ушкалова Е.А.

Российский кардиологический журнал. Vol. 25. 2020. P.. 96-106

Page 1 of 3. Records 1 to 15 of 38

Other authors

Rodionova Irina

Records: 1

Mischenko A.V.

Records: 3